ABCA1, a downstream gene target of these nuclear receptor pathways, has been consistently and independently shown to protect against AD phenotypes in animals[209–212] and an epidemiological study in Denmark identified a loss of function ABCA1 gene as a risk factor for both AD and cerebrovascular disease[213]. This evidence concerns the gene ABCA1 and cerebrovascular disorder.